Calafiore Massimo 4

What Happened
Massimo Calafiore, President & CEO and a director of Orthofix Medical (OFIX), disposed of 12,220 shares in two open-market transactions: 6,189 shares on 2026-03-04 at a weighted average price of $12.92 (proceeds $79,939) and 6,031 shares on 2026-03-05 at a weighted average price of $12.55 (proceeds $75,694). Total proceeds were about $155,633. These sales were made to satisfy tax-withholding obligations related to the settlement of restricted stock units (RSUs), not reported as discretionary trades by the insider.

Key Details

• Transaction dates and prices:
  • 2026-03-04: 6,189 shares sold, weighted avg price $12.92 (range $12.80–$13.03 per footnote)
  • 2026-03-05: 6,031 shares sold, weighted avg price $12.55 (range $12.48–$12.72 per footnote)
• Total shares sold: 12,220; total proceeds ≈ $155,633.
• Shares owned after transaction: not explicitly stated in the provided summary; filing notes include 221,042 previously reported RSUs (footnote F3).
• Footnotes:
  • F1: Sales were to satisfy tax withholding on RSU settlement via a pre-existing, mandatory sell-to-cover arrangement approved by the Compensation and Talent Development Committee; sales made without the reporting person’s discretion.
  • F2/F4: Reported prices are weighted averages; multiple execution prices within the stated ranges.
• Filing timeliness: Form 4 filed 2026-03-06 for transactions on 2026-03-04 and 2026-03-05; appears to be filed within the usual Form 4 reporting window.

Context
These were sell-to-cover tax-withholding sales tied to RSU settlement (routine administrative transactions), which are generally not read as an indicator of the insider’s market view. No option exercises, gifts, or discretionary open-market selling were reported.